- Research
- 2022-2026 Research Strategy
- Open Clinical Trials
- Closed Clinical Trials
- What is a Clinical Trial?
- Why Participate in a Clinical Trial
- Remote Telehealth Pre-Screening Process
- Research Achievements
- Publications
- Research Development and Funding
- Participating Institutions
- International Collaboration
- BCT Trials & Projects Summary
- Translational Research
- Clinical Fellowship Program
- International Fellowship Support
- Annual Scientific Meeting
- Travel Grants and Awards
- About
- Our Impact
- Fundraise
- Donate
- Researcher Login
- Cart
HABITS
Closed
IBCSG 17-98/BIG 3-97: HABITS
BCT Study Chair:
John Forbes
A randomised clinical trial concerning hormonal replacement therapy (HRT) after previous radical breast cancer treatment.
433
INTERNATIONAL
Total number of trial
participants internationally
15
AUSTRALIA & NEW ZEALAND
Total number of trial participants
in Australia and New Zealand
7
INSTITUTIONS
Total number of participating institutions
in Australia and New Zealand
HABITS PUBLICATIONS
2008
Should observational studies be a thing of the past?
Pritchard KI. JNCI 2008; 100(7):451, Journal
Increased risk of recurrence after hormone replacement therapy in breast cancer survivors.
Holmberg L, Iversen O-E, Rudenstam CM, Hammar M, Kumpulainen E, Jaskiewicz J, Jassem J, Dobaczewska D, Fjosne HE, Peralta O, Arriagada R, Holmqvist M, Maenpa J. J Natl Cancer Inst 2008; 100475-482, Journal
2005
Early stopping of clinical trials.
Cuzick J, Howell A, Forbes J. Breast Cancer Research 2005; 7181-183, Commentary
2004
HABITS (hormonal replacement therapy after breast cancer – is it safe?), a randomised comparison: trial stopped.
Holmberg L, Anderson H, for the HABITS steering and data monitoring committees. Lancet 2004; 363453-455, Letter